HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression.

Abstract
Definitions of the metabolic syndrome (MetS) include obesity, dyslipidemia, elevated levels of fasting blood glucose, and blood pressure as criteria, but it is also known that the MetS is associated with chronic, subclinical inflammation. Hyperglycemia (fasting and postprandial) may be important in exacerbating this proinflammatory state. We aimed to assess the impact of oral glucose challenge and in vitro glucose-stimulation on gene expression and secretion of inflammatory parameters in peripheral blood leukocytes and to investigate whether presence of the MetS could "prime" leukocytes to up-regulate proinflammatory markers in response to glucose. Using quantitative real-time PCR, we could show that the expression of intercellular adhesion molecule 1 (ICAM-1), tumor necrosis factor alpha (TNF-alpha), and interleukin 6 (IL-6) significantly increased in peripheral blood leukocytes from "MetS" subjects (n=39) compared to "no MetS" subjects (n=35) 2 h after an oral glucose tolerance test (ICAM-1 +52%, TNF-alpha +107%, and IL-6 +38%) and also in vitro after 72 h cultivation in high-glucose medium (ICAM-1 +74%, TNF-alpha +71%, and IL-6 +44%). Using ELISA and Luminex technique, we further observed a trend towards increased immune mediator concentrations in the corresponding cell culture supernatants from MetS patients (ICAM-1 +21%, TNF-alpha +31%, and IL-6 +175%). Thus, the MetS may support peripheral inflammation by sensitizing leukocytes to up-regulate proinflammatory markers in response to glucose, which in turn increases the risk for type-2 diabetes mellitus and cardiovascular disease.
AuthorsK Kempf, B Rose, C Herder, B Haastert, A Fusbahn-Laufenburg, A Reifferscheid, W A Scherbaum, H Kolb, S Martin
JournalJournal of molecular medicine (Berlin, Germany) (J Mol Med (Berl)) Vol. 85 Issue 4 Pg. 389-96 (Apr 2007) ISSN: 0946-2716 [Print] Germany
PMID17160670 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • Glucose
Topics
  • Gene Expression Regulation (drug effects)
  • Glucose (pharmacology)
  • Humans
  • Hyperglycemia (immunology, metabolism)
  • Immune System (drug effects, metabolism)
  • Intercellular Adhesion Molecule-1 (analysis, genetics)
  • Interleukin-6 (analysis, blood)
  • Leukocytes (physiology)
  • Metabolic Syndrome (blood, complications, immunology, pathology)
  • Tumor Necrosis Factor-alpha (analysis, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: